UPDATED May 08, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
7373 | JP¥1,745.00 | 1.7% | -33.8% | JP¥26.6b | JP¥4,600.00 | PE23.4x | E28.1% | n/a | Commercial Services | ||
CYC | AU$1.80 | 2.6% | -16.1% | AU$169.1m | AU$4.35 | PS6.2x | E89.2% | 0% | Healthcare | ||
IRISDOREME | ₹78.65 | 0.2% | 10.3% | ₹6.4b | ₹101.00 | PE58.6x | E51.4% | n/a | Consumer Durables | ||
A080160 | ₩16,680.00 | -0.6% | -1.4% | ₩294.4b | ₩17,666.67 | PE64.5x | E67.7% | 1.5% | Consumer Services | ||
HHR | AU$0.007 | 0% | -77.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
A439090 | ₩22,650.00 | -3.0% | n/a | ₩371.0b | n/a | PE31.9x | E49.6% | n/a | Household | ||
A254490 | ₩18,800.00 | 0.5% | 1.1% | ₩271.4b | n/a | PE53.6x | E75.7% | n/a | Tech | ||
688793 | CN¥31.86 | -3.4% | -3.7% | CN¥2.7b | CN¥37.52 | PS2x | E68.6% | 0% | Household | ||
A108860 | ₩17,320.00 | 3.9% | -5.8% | ₩466.2b | n/a | PS8.8x | E98.9% | n/a | Software | ||
3DA | AU$0.49 | 17.9% | 253.6% | AU$268.1m | n/a | PS319.6x | E80.5% | n/a | Capital Goods | ||
CAI | AU$0.13 | 0% | -29.7% | AU$99.0m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
5038 | JP¥1,406.00 | 3.4% | -31.3% | JP¥21.0b | n/a | PE34.4x | E24.7% | n/a | Healthcare | ||
A179900 | ₩35,100.00 | 0% | 60.3% | ₩555.3b | ₩60,000.00 | PS28.7x | E111.6% | 0% | Tech | ||
517522 | ₹601.15 | -3.7% | -23.8% | ₹30.5b | ₹772.00 | PE42.5x | E33.5% | 0.3% | Materials | ||
A036200 | ₩10,460.00 | -5.2% | 42.5% | ₩312.6b | ₩13,500.00 | PE17.1x | E38.6% | 0.8% | Semiconductors | ||
YGG | ฿7.05 | 4.4% | -4.7% | ฿4.2b | ฿10.75 | PE61.1x | E34.7% | 3.8% | Media | ||
ADOC | €9.00 | 7.7% | 148.6% | €128.6m | €9.70 | PS21.3x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €9.50 | 0% | 1.1% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
GWIND | ₺29.10 | 2.7% | 109.0% | ₺15.7b | ₺39.79 | PE25.2x | E60.9% | 1.6% | Utilities | ||
AGP | €8.30 | 4.9% | 151.5% | €143.7m | €12.75 | PE29.2x | E22.8% | n/a | Capital Goods | ||
KEBNI B | kr1.48 | -6.8% | 40.8% | kr402.4m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
NEWBRY | kr3.06 | -10.3% | -45.4% | kr74.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.96 | 3.6% | -44.1% | US$241.7m | US$25.90 | PS4.6x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł2.15 | 7.5% | 31.5% | zł75.3m | zł3.71 | PE14.9x | E30.8% | n/a | Diversified Financials |